OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 186,900
+5,100 (2.81%)
At close: Mar 20, 2026
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 3.77 trillion as of March 20, 2026. Its market cap has increased by 373.74% in one year.
Market Cap
3.77T
Enterprise Value
3.67T
Revenue
14.67B
Ranking
n/a
PE Ratio
n/a
Stock Price
186,900.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 3.77T, an increase of 794.14%. That is a compound annual growth rate of 33.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.77T | 33.12% |
| Dec 30, 2025 | 2.83T | 697.30% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Peptron | 8.07T |
| LigaChem Biosciences | 7.75T |
| SK Biopharmaceuticals | 7.72T |
| HLB Co., Ltd. | 6.87T |
| Voronoi | 5.84T |
| D&D Pharmatech | 3.40T |
| PharmaResearch | 3.38T |
| SK bioscience | 3.36T |